These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32362179)

  • 21. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of hepatitis B infection in health care workers after accidental exposure.
    Palmović D
    J Infect; 1987 Nov; 15(3):221-4. PubMed ID: 2961815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of seroconversion following treatment with hepatitis B immune globulin containing antibody to human immunodeficiency virus.
    Phillips M; Cummins LM
    Hepatology; 1988; 8(3):497-8. PubMed ID: 3371869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
    Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative immune globulin preparation when standard immune serum globulin is not available.
    Lutwick LI; Wu EH
    JAMA; 1991 Mar; 265(9):1114. PubMed ID: 1995995
    [No Abstract]   [Full Text] [Related]  

  • 26. Tourist hepatitis, antibodies to hepatitis A virus and immune serum globulin prophylaxis.
    Iwarson S; Frösner G; Norkrans G
    Infection; 1978; 6(6):257-8. PubMed ID: 215556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
    Han SH; Martin P; Edelstein M; Hu R; Kunder G; Holt C; Saab S; Durazo F; Goldstein L; Farmer D; Ghobrial RM; Busuttil RW
    Liver Transpl; 2003 Feb; 9(2):182-7. PubMed ID: 12548512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake and elimination of hepatitis B immunoglobulins after intramuscular application in man.
    Scheiermann N; Kuwert EK
    Dev Biol Stand; 1983; 54():347-55. PubMed ID: 6653890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulins for preventing hepatitis A.
    Liu JP; Nikolova D; Fei Y
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004181. PubMed ID: 19370595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune serum globulin for protection against viral hepatitis. Recommendation of the Public Health Service Advisory Committee on Immunization Practices.
    Ann Intern Med; 1972 Sep; 77(3):427-30. PubMed ID: 4115456
    [No Abstract]   [Full Text] [Related]  

  • 31. Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.
    Young MK; Cripps AW
    Hum Vaccin Immunother; 2013 Sep; 9(9):1885-93. PubMed ID: 23783220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
    Yao FY; Osorio RW; Roberts JP; Poordad FF; Briceno MN; Garcia-Kennedy R; Gish RR
    Liver Transpl Surg; 1999 Nov; 5(6):491-6. PubMed ID: 10545536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis of hepatitis A with immune globulin.
    Braithwaite MG
    J R Army Med Corps; 1983 Jun; 129(2):88-92. PubMed ID: 6620245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive immunization against hepatitis A.
    Stapleton JT
    Vaccine; 1992; 10 Suppl 1():S45-7. PubMed ID: 1335658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination.
    Sirikun J; Suputtamongkol Y; Rattanachinakorn P; Primsirikunawut A
    Vaccine; 2018 Jan; 36(2):285-291. PubMed ID: 29191737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects.
    Aoki FY; Rubin ME; Friesen AD; Bowman JM; Saunders JR
    J Biol Stand; 1989 Jan; 17(1):91-104. PubMed ID: 2646301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoprophylaxis of hepatitis A of the children by immune serum globulin.
    Kinoshita R; Hirose S; Miura K; Nakagawa T; Imai Y; Suzuki S
    Gastroenterol Jpn; 1984 Jun; 19(3):211-5. PubMed ID: 6086439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive immunization against hepatitis B: a review of recent studies and comment on current aspects of control.
    Maynard JE
    Am J Epidemiol; 1978 Feb; 107(2):77-86. PubMed ID: 341692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation.
    Lee WC; Chou HS; Wu TH; Cheng CH; Lee CF; Wang YC; Wu TJ; Chan KM
    Transpl Infect Dis; 2019 Dec; 21(6):e13190. PubMed ID: 31587427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.